The EMA’s CHMP has recommended EU approval of Lynavoy for [...]
The EMA’s CHMP has recommended approval of NEZGLYAL for boys [...]
Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]
NICE recommends Mirikizumab for moderately to severely active Crohn’s Disease after biologic failure
Mirikizumab is now recommended by NICE for routine NHS use [...]
Regulators back AI and organ-on-a-chip technologies to modernize safety evaluation [...]
The National Institute for Health and Care Excellence (NICE) has [...]
Eton Pharmaceuticals has received US regulatory approval for Khindivi, the [...]